Search Results
Aug 19, 2026, 07:55 ET Core Natural Resources Advances its Executive Succession Plan
CANONSBURG, Pa., Aug. 19, 2026 /PRNewswire/ -- Today, Core Natural Resources, Inc. (NYSE: CNR) ("Core" or the "company") announced that – as part of its long-term succession process – Core's president, Mitesh Thakkar, is assuming an expanded role
More news about: Core Natural Resources
Aug 17, 2026, 08:00 ET Independent Whitepaper Validates Amirix Imaging's LM33-T X-ray Tube for Hologic Mammography Systems
quality, evaluated using ACR phantom scoringSignal-to-noise ratio (SNR)Contrast-to-noise ratio (CNR)Findings and resultsThe results reveal that the
More news about: Amirix Imaging
Aug 06, 2026, 06:55 ET Core Natural Resources Reports Second Quarter 2026 Results
CANONSBURG, Pa., Aug. 6, 2026 /PRNewswire/ -- Today, Core Natural Resources, Inc. (NYSE: CNR) ("Core" or the "company") reported net income of $126.5 million, or $2.51 per diluted share, in the second quarter of 2026. Additionally, Core reported
More news about: Core Natural Resources
Jul 23, 2026, 07:55 ET Core Natural Resources to Announce Second Quarter 2026 Results on August 6
CANONSBURG, Pa., July 23, 2026 /PRNewswire/ -- Core Natural Resources, Inc. (NYSE: CNR) will discuss its second quarter 2026 financial results on an investor conference call on Thursday, August 6, 2026, at 10:00 a.m. Eastern time.
More news about: Core Natural Resources
Jul 06, 2026, 06:55 ET US Department of Energy Announces Selection of Core Natural Resources' Innovations Group to Pursue Critical Mineral and Material Extraction from Coal
Pa., July 6, 2026 /PRNewswire/ -- CONSOL Innovations LLC, a subsidiary of Core Natural Resources (NYSE: CNR), has been selected for a multi-million-dollar grant awarded by the U.S. Department of Energy's (DOE) Office of Critical Minerals and Energy Innovation.
More news about: Core Natural Resources
Jun 01, 2026, 13:38 ET Banco Rendimento amplia atuação internacional com conta exclusiva para brasileiros e estrangeiros não residentes
esse público ao sistema bancário nacional. De olho nesse cenário, o Banco Rendimento fortalece sua estratégia global com a Conta para Não Residente (CNR), voltada a brasileiros e estrangeiros sem residência fiscal no país, que precisam manter movimentações financeiras no Brasil.
More news about: Rendimento
May 19, 2026, 07:38 ET Touchstone Advanced Composites, a Core Natural Resources Company, Supports Development of Northrop Grumman's YFQ-48A Talon Blue Autonomous Aircraft
May 19, 2026 /PRNewswire/ -- Touchstone Advanced Composites, part of the Innovations business unit of Core Natural Resources (NYSE: CNR), is fabricating complex structural tooling for Northrop Grumman's next-generation YFQ-48A Talon Blue Collaborative Combat Aircraft (CCA). Touchstone
More news about: Core Natural Resources
May 13, 2026, 07:58 ET Core Promotes Braithwaite to Chief Commercial Officer
CANONSBURG, Pa., May 13, 2026 /PRNewswire/ -- Today, Core Natural Resources, Inc. (NYSE: CNR) ("Core," the "company," "we" or "our") announced the promotion of Robert Braithwaite to senior vice president and chief commercial officer, effective
More news about: Core Natural Resources
May 07, 2026, 06:55 ET Core Natural Resources Reports First Quarter 2026 Results
CANONSBURG, Pa., May 7, 2026 /PRNewswire/ -- Today, Core Natural Resources, Inc. (NYSE: CNR) ("Core" or the "company") reported net income of $21.0 million, or $0.41 per diluted share, in the first quarter of 2026. Additionally, Core reported
More news about: Core Natural Resources
Apr 30, 2026, 16:30 ET Ted Doheny and Ron Keating Elected to Core Natural Resources' Board of Directors
CANONSBURG, Pa., April 30, 2026 /PRNewswire/ -- Today, Core Natural Resources, Inc. (NYSE: CNR) ("Core," the "company," "we" or "our") announced that Edward L. Doheny II and Ronald C. Keating have been elected to its board of directors at Core's
More news about: Core Natural Resources
Apr 23, 2026, 08:00 ET Core Natural Resources to Announce First Quarter 2026 Results on May 7
CANONSBURG, Pa., April 23, 2026 /PRNewswire/ -- Core Natural Resources, Inc. (NYSE: CNR) will discuss its first quarter 2026 financial results on an investor conference call on Thursday, May 7, 2026, at 10:00 a.m. Eastern time.
More news about: Core Natural Resources
Feb 19, 2026, 13:35 ET MASON CAPITAL MANAGEMENT DEMANDS ANSWERS FROM ASCENT CNR CORPORATION
2026Board of DirectorsAscent CNR Corporation3501 NW 63rd StreetOklahoma City, OK 73116Ascent CNR CorporationC/O Corporation Trust Company1209 Orange StreetWilmington, DE 19801Ascent CNR CorporationC/O Robert W. Kelly II3501
More news about: Mason Capital Management
Feb 12, 2026, 06:55 ET Core Natural Resources Reports Fourth Quarter 2025 Results
CANONSBURG, Pa., Feb. 12, 2026 /PRNewswire/ -- Today, Core Natural Resources, Inc. (NYSE: CNR) ("Core" or the "company") reported a net loss of $79.0 million, or ($1.54) per diluted share, in the fourth quarter of 2025. Additionally, Core reported
More news about: Core Natural Resources
Feb 11, 2026, 09:11 ET IRBM 公布寨卡病毒藥物研發取得突破
憑藉數十年的專業經驗及成功交付創新臨床前候選藥物的良好往績，IRBM 以其嚴謹、多學科整合的研究方法而聞名，能夠設計並執行複雜實驗，以應對最具挑戰性的藥物研發難題。 IRBM 在多元技術平台及治療領域推進多項研發計劃，涵蓋抗病毒、腫瘤學、神經科學、罕見疾病等範疇，並持續拓展至更多領域。關於 CNCCS CNCCS 是一個由 IRBM、CNR、ISS 及羅馬大學 (University of La Sapienza) 組成的公私合營聯盟，作為藥物研發計劃的核心推動平台，整合化學化合物資源庫與高吞吐量篩選 (HTS) 平台。 其使命是成為連接學術研究與製藥開發之間的橋樑，特別專注於針對罕見、被忽視及與貧困相關的疾病。 網站：
More news about: IRBM S.p.A.
Feb 10, 2026, 11:13 ET IRBM、ジカウイルス治療薬の発見において画期的な進展を報告
疾患など、幅広いモダリティと治療領域にわたってプログラムを推進しています。CNCCSについてCNCCSは、IRBM、CNR、ISS、およびラ・サピエンツァ大学による官民コンソーシアムであり、化合物リポジトリとハイスループットスクリーニング（HTS）プラットフォームを統合し、創薬プログラムのリードファクトリーとして機能しています。その使命は、学術研究と医薬品開発の架け橋となることであり、特に希少疾患、顧みられない疾患、および貧困に関連する疾患への取り組みに重点を置いています。ウェブサイト：
More news about: IRBM S.p.A.
Feb 10, 2026, 11:10 ET IRBM Relata Avanço na Descoberta de Medicamentos para o Zika Vírus
incluindo antivirais, oncologia, neurociência, doenças raras e muito mais.Sobre o CNCCS O CNCCS é um consórcio público-privado entre o IRBM, o CNR, a ISS e a Universidade de La Sapienza, que atua como uma fábrica líder para programas de descoberta de medicamentos, integrando um repositório de compostos
More news about: IRBM S.p.A.
Feb 10, 2026, 11:04 ET IRBM informa sobre un gran avance en el descubrimiento de fármacos contra el virus del Zika
terapéuticas, incluidos antivirales, oncología, neurociencia, enfermedades raras y más.CNCCS es un consorcio público-privado entre IRBM, CNR, ISS y la Universidad de La Sapienza, que actúa como una fábrica líder para los programas de descubrimiento de fármacos, integrando un repositorio de
More news about: IRBM S.p.A.
Feb 10, 2026, 09:25 ET IRBM informa sobre un avance en el descubrimiento de un fármaco contra el virus del Zika
antivirales, oncología, neurociencia, enfermedades raras y más.Acerca del CNCCS: El CNCCS es un consorcio público-privado entre IRBM, CNR, ISS y la Universidad de La Sapienza, que actúa como centro de investigación líder para programas de descubrimiento de fármacos, integrando un repositorio
More news about: IRBM S.p.A.
Feb 10, 2026, 09:13 ET L'IRBM fait état d'une avancée dans la découverte d'un médicament contre le virus Zika
l'oncologie, les neurosciences, les maladies rares et d'autres encore.À propos du CNCCS Le CNCCS est un consortium public-privé entre l'IRBM, le CNR, l'ISS et l'université de La Sapienza, qui agit en tant qu'usine principale pour les programmes de découverte de médicaments, en intégrant un dépôt de
More news about: IRBM S.p.A.
Feb 10, 2026, 07:10 ET IRBM meldet Durchbruch bei der Entdeckung von Medikamenten gegen das Zika-Virus
Neurowissenschaften, seltener Krankheiten und darüber hinaus.Über das CNCCS Das CNCCS ist ein öffentlich-privates Konsortium aus IRBM, CNR, ISS und der Universität La Sapienza, das als Lead Factory für Arzneimittelentdeckungsprogramme fungiert, indem es ein Depot für chemische Verbindungen
More news about: IRBM S.p.A.
Feb 10, 2026, 06:00 ET IRBM Reports Breakthrough in Zika Virus Drug Discovery
including antivirals, oncology, neuroscience, rare diseases, and beyond.About CNCCS CNCCS is a public-private consortium between IRBM, CNR, ISS, and the University of La Sapienza, which acts as a lead factory for drug discovery programs, integrating a chemical compound repository with a
More news about: IRBM S.p.A.
Feb 10, 2026, 06:00 ET IRBM Reports Breakthrough in Zika Virus Drug Discovery
including antivirals, oncology, neuroscience, rare diseases, and beyond.About CNCCS CNCCS is a public-private consortium between IRBM, CNR, ISS, and the University of La Sapienza, which acts as a lead factory for drug discovery programs, integrating a chemical compound repository with a
More news about: IRBM S.p.A.
Feb 10, 2026, 06:00 ET Ricerca IRBM: un passo avanti verso nuove terapie contro il virus Zika
ricerca scientifica in nuove terapie concrete per i pazienti.CNCCS: Il CNCCS è un consorzio pubblico-privato che riunisce IRBM, CNR, ISS e l'Università La Sapienza, creando un hub innovativo per la scoperta di nuovi farmaci. Grazie a un'ampia collezione di composti chimici,
More news about: IRBM S.p.A.
Feb 04, 2026, 17:00 ET MASON CAPITAL MANAGEMENT REITERATES SERIOUS CONCERNS REGARDING ASCENT RESOURCES TRANSACTIONS
correspondence addressed specific contractual and economic rights held by Mason Capital through CNR.To be clear:Mason holds enforceable contractual and economic interests through CNR that are being directly affected by the Board's actions and refusal to act.The Board's
More news about: Mason Capital Management
Jan 30, 2026, 08:30 ET Core Natural Resources to Announce Fourth Quarter 2025 Results on February 12
CANONSBURG, Pa., Jan. 30, 2026 /PRNewswire/ -- Core Natural Resources, Inc. (NYSE: CNR) will discuss its fourth quarter 2025 financial results on an investor conference call on Thursday, February 12, 2026 at 10:00 a.m. Eastern time.
More news about: Core Natural Resources